DRAI Health Appoints Benjamin Segal to Board

DRAI Health, Inc. announced on May 5, 2026 that it has appointed Benjamin Segal, a Managing Director in private wealth at UBS Wealth Management, to its Board of Directors, according to a PR Newswire release. The release states the appointment is intended to strengthen executive leadership and corporate governance as the company scales its platform across consumer, enterprise, and institutional healthcare markets. The release quotes Mr. Segal: "DRAI Health is addressing inefficiencies in healthcare by leveraging AI to improve patient access and support better clinical decision-making." The release also quotes Dr. Mohan Ananda, Founder and Executive Chairman: "Benjamin's perspective as a trusted advisor to sophisticated investors and business leaders will be a critical asset as we continue to scale DRAI Health's AI healthcare platform."

The PR Newswire release frames DRAI Health as a healthcare technology company combining AI and human expertise to deliver preventive care and clinical decision support. The release highlights Mr. Segal's background advising high-net-worth individuals, family offices, and institutions on long-term investment strategy, capital allocation, and risk management, and notes his experience spans public and private markets.

Industry observers note board additions of finance and wealth-management veterans are a common move for growth-stage healthtech companies seeking credibility with investors and institutional partners. Such appointments often bring expertise in capital allocation, investor relations, and evaluating high-growth technology opportunities, which can matter for fundraising and commercial partnerships.

Track any subsequent public filings, partnership announcements, or financing activity where DRAI Health cites board governance changes. Observers should also watch for executive biographies and investor materials that reflect how the company communicates its AI and clinical value proposition.